Glimzab MV2

Glimepiride 2mg +Metformin SR 500mg + Voglibose 0.3mg

Description:

Glimzab MV is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise.

Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas.

Metformin works by lowering the glucose production in the liver and improving insulin sensitivity.

Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body.
Indications:

Used in the treatment of Type 2 Diabetes Mellitus (DM).

Composition:
Glimzab MV2

Composition :
Each uncoated bilayered tablet contains:
Glimepiride IP 2mg
Voglibose IP 0.3mg
Metformin Hydrochloride IP 500mg
(as sustained release form)
Excipients q.s.
Colour : Ferric Oxide Red USP-NF, Ferric Oxide Yellow USP-NF & Ferric Oxide Balck USP-NF